Clinical Trial Update: Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 safety and efficacy trial of CNOP chemotherapy for diffuse large B-cell lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CNOP chemotherapy

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Diffuse Large B Cell Lymphoma | Phase 1 | Status: WITHDRAWN